Skip to main content
Editorial
The inaugural HEMA report: a missed opportunity for comprehensive value assessment
- Kimberly Westrich,
- Tyler D Wagner, and
- Jonathan D Campbell
e260049
Published Online:18 March 2026
Industry Update
Access in all areas? A round-up of developments in market access and health technology assessment: part 14
- Sreeram V Ramagopalan and
- Annie Jullien Pannelay
e260056
Published Online:26 March 2026
Research Article
Readmissions and retreatment among stent-assisted endovascular coiling patients with unruptured intracranial aneurysm using ENTERPRISE® 2 stent versus LVIS™ stent
- Reade De Leacy,
- Rahul Khanna,
- Emilie Kottenmeier, and
- Yiran Rong
e250166
Published Online:13 April 2026
Health economic analysis of pulsed field ablation compared to conventional thermal ablation for patients with paroxysmal atrial fibrillation in China
- Jian Ye,
- Youqi Fan,
- Ye Wang,
- Yifei Jian,
- Yue Gao,
- Shuting Chen,
- Jianwei Xuan, and
- Hesheng Hu
e250153
Published Online:29 April 2026
Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe
- Ellen Brodin,
- Annie Young,
- Florian Langer,
- Raza Alikhan,
- Lauri Timo,
- Dimitra Lambrelli,
- Beth Nordstrom,
- Alison Booth,
- Sophie Graham,
- Ruth Mokgokong,
- Aaron Jenkins,
- Jose Chaves,
- Feng Dai,
- Rupesh Subash,
- Moritz Lehne,
- Marco Ghiani,
- Antje Mevius,
- Daniela Fliegner, and
- Anders Gottsäter
e250072
Published Online:1 May 2026
Real-world evidence on the use of hospital resources for subcutaneous and intravenous trastuzumab administration in breast cancer patients at a referral public hospital in Mexico
- Tatiana Fiordelisio,
- Francisco Valdés-Souto,
- Diana del-Rio Valdes,
- Diego Zamarrón Hernández,
- Karla Ramírez Pulido,
- Cristopher Alejandro Escamilla Soto,
- Yair Uriel Correa Trejo,
- Claudia Itzel Gutiérrez Sánchez,
- Isabel Espino Gutiérrez, and
- Claudia Haydeé Arce Salinas
e250199
Published Online:20 April 2026
Advancements from the EVOLVE study for assessing real-world experience with eteplirsen, golodirsen and casimersen for the treatment of DMD
- Cuixia Tian,
- Shannon Grabich,
- Aravindhan Veerapandiyan,
- Rebecca J Scharf,
- Sourav Santra,
- Shane Hornibrook,
- Kerri Drummond,
- Ihor Sehinovych, and
- Megan Waldrop
e250108
Published Online:10 April 2026
Switching adult patients with spasticity from onabotulinumtoxinA to abobotulinumtoxinA: a real-world data analysis across three US-based treatment centers
- Nate Way,
- Edward Dabrowski,
- Mitchell Paulin,
- Martin Taylor,
- John Madden,
- Amandeep Mann, and
- Jonathan Bouchard
e250181
Published Online:1 May 2026
Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017–2024): a retrospective cohort study
- Uche Mordi,
- Mary J Christoph,
- Benjamin Chastek,
- Travis Lim,
- Neia Prata Menezes,
- Sunil Majethia,
- Lisa B Le, and
- Joshua Cohen
e250124
Published Online:23 April 2026
Clinical outcomes of pressure-enabled drug delivery for trans-arterial chemoembolization and radioembolization
- Deepshekhar Gupta,
- Yunjuan Liu,
- Chris Miller-Rosales,
- Fangzhou Wei,
- Edward Tuttle,
- Ekaterina Byers,
- Richard Marshak, and
- Richard Marshall
e250144
Published Online:9 April 2026
Meta-Analysis
Network meta-analysis: relative clinical efficacy and safety of elafibranor versus seladelpar as second-line treatment for patients with primary biliary cholangitis
- David Jones,
- Emily Combe,
- Harun Knight,
- Vicki Laskier-Owens,
- Shijie Ren,
- Tom Wright,
- Elaine A Böing, and
- Alex Pashley
e250206
Published Online:17 April 2026
Perspective
Maximizing the impact of real-world evidence on cancer treatment: what do we need to achieve it?
- Begoña Bermejo,
- Rodrigo Dienstmann,
- Meritxell Bellet,
- Susana de la Cruz,
- Elena Galve-Calvo,
- Verónica Obadia,
- Ana Santaballa,
- Rocío Ramos-Medina,
- Mónica Cuenca, and
- Fernando Moreno
e250186
Published Online:24 April 2026